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Abstract 
Harmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to 
ensure that the prescribing competency of future doctors is of an uniform high standard. As there are 
currently no uniform requirements, our aim was to achieve consensus on key learning outcomes for 
undergraduate CPT education in Europe. We used a modified Delphi method consisting of three 
questionnaire rounds and a panel meeting. 129 experts from 27 European countries were asked to 
rate 307 learning outcomes. 92 experts (71%) completed all three questionnaire rounds, and 33 
experts (26%) attended the meeting. 232 learning outcomes from the original list, 15 newly suggested 
and 5 rephrased outcomes were included. These 252 learning outcomes should be included in 
undergraduate CPT curricula to ensure that European graduates are able to prescribe safely and 
effectively. We provide a blueprint of a European core curriculum describing when and how the 
learning outcomes might be acquired. 
 
 
  
This article is protected by copyright. All rights reserved.
6 
 
Introduction  
Prescribing is a complex and challenging task for every medical graduate. Poor prescribing may result 
in medication errors and adverse drug reactions with potential consequences for patient safety and 
healthcare costs.1,2 In many European countries, recently graduated doctors write a large proportion of 
prescriptions in hospitals, often with minimal supervision from senior clinicians. In order to prescribe 
safely and effectively at the start of their professional careers, medical graduates should have 
acquired appropriate prescribing competencies (i.e., knowledge, skills, and attitudes). Unfortunately, 
studies throughout Europe suggest that medical students have not acquired these necessary 
competencies by the time they graduate. In the UK and the Netherlands, recent graduates were found 
to be responsible for a large number of prescribing errors and reported having little confidence in their 
prescribing skills.3-6 In other European countries, there are similar concerns about a lack of prescribing 
competencies among medical graduates.7 A recent multicenter study showed a general lack of 
essential prescribing competencies among 895 final-year medical students from 17 European medical 
schools.8 This is even more worrying since the demands on new prescribers are increasing 
progressively because of several trends, including a growing number of medicines, increasingly 
vulnerable patients, and more complicated regimens due to polypharmacy and multimorbidity.9  
Poor education in clinical pharmacology and therapeutics (CPT) during the undergraduate 
medical curriculum may underlie the lack of prescribing competencies among recent graduates. 
Indeed, most final-year students of European medical schools felt that their medical curriculum had not 
adequately prepared them for safe prescribing and thought that too little time had been devoted to 
CPT.8 Moreover, a recent study showed there to be a marked variation in the quantity and quality of 
CPT education in European medical schools.10 In most schools, both teaching and assessment are 
mainly based on traditional learning methods (e.g., lectures and written examinations), which seem to 
be associated with a lower level of prescribing knowledge and skills among final-year students 
compared with problem-based learning methods (e.g., patient simulation and real-life prescribing).8 
Modernizing and harmonizing CPT education at a European level might prevent and reduce 
prescribing errors in the future, thereby improving patient safety. Furthermore, harmonization is 
becoming more important given the increased mobility of medical students and junior doctors across 
Europe.11 
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A first step toward harmonization is to establish which learning outcomes should be common 
to all European undergraduate CPT curricula, as suggested by the British Pharmacological Society 
(BPS) and the European Association of Clinical Pharmacology and Therapeutics (EACPT) in 2007.7 
Defining clear learning outcomes might also help to shape and strengthen the CPT specialty in Europe, 
since it has lost ground in recent decades and has become increasingly invisible in medical curricula.12 
Previous studies of CPT learning outcomes have mostly come from the UK,9,13-15 the Netherlands,16 
and Sweden.17 To date, there has been no clear and robust definition of what European medical 
graduates should know about CPT in order to prescribe safely and effectively. Therefore, on behalf of 
the Education Working Group of the EACPT, we conducted this modified Delphi study to reach 
consensus on key learning outcomes for teaching and assessing CPT during the undergraduate 
medical training in Europe. 
  
This article is protected by copyright. All rights reserved.
8 
 
Results 
In total, 129 (129/177; 73%) experts from 27 European countries accepted the invitation and formed 
the consensus panel. Their characteristics are presented in Table S1. The response rate was 85% 
(109/129), 74% (95/129), 81% (104/129) for Rounds 1, 2, and 3, respectively.  Ninety-two experts 
(71%) from 25 European countries completed all three rounds (79 doctors, 9 pharmacists, and 4 
scientists). The average educational experience of all panellists was 17.5 years (range 3–38); 78% of 
the medical doctors were clinical pharmacologists. Thirty-three panellists (26%) from 17 European 
countries attended the face-to-face meeting (Table S1).  
 
Delphi process 
The flow chart of the systematic literature search is shown in Figure 1. The articles identified in the 
literature search are presented in Table S2. During Round 1, 226 of the 307 outcomes were included; 
81 outcomes for which there was no consensus about their relevance, 24 new outcomes, and 2 
adapted outcomes were re-submitted in Round 2. During Round 2, 18 of the 107 resubmitted 
outcomes were included, 73 were excluded, and 16 were selected for discussion during the panel 
meeting (75–80% agreement). During the panel meeting, 5 of the 16 outcomes were included, 6 were 
excluded, and 5 were adapted and resubmitted in Round 3. In this round, 3 of the 5 adapted outcomes 
were included, giving a total of 252 outcomes (34 subcategories; 192 knowledge, 47 skills, and 13 
attitudes) considered important for CPT education in Europe. The subcategories are shown in Table 1 
and the detailed learning outcomes are listed in Table S3-5. Most panellists indicated that 201 of the 
252 included outcomes (80%) should be acquired during the clinical years of the undergraduate 
medical curriculum, 33 (13%) outcomes should be acquired during the pre-clinical years, and 18 (7%) 
during both phases (Table S3-5). Although most of the included outcomes focused on knowledge 
(76%), outcomes regarding prescribing skills and attitudes were generally considered more important 
(Figure 2). 63 outcomes did not meet the 80% agreement cut-off and were excluded (47 knowledge, 
14 skills, and 2 attitudes).  
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Discussion 
In this study, an international panel of experts identified 252 key learning outcomes for CPT education 
in European medical schools. These learning outcomes provide a detailed description of 
competencies that European medical graduates should have acquired in order to prescribe safely and 
effectively. To our knowledge, this is the first Delphi study to establish CPT learning outcomes at a 
European level. Previous studies of CPT learning outcomes that used the Delphi technique were 
mainly focused on the local setting in a specific country.14,15,17 Our Delphi study provides additional 
information that builds on earlier CPT curricula,9,13,15,18 and offers a detailed framework for teaching 
and assessing CPT in European medical curricula, that could also be useful elsewhere (e.g. USA). 
Implementing the identified learning outcomes in already overcrowded medical curricula will be 
challenging but essential in order to improve the prescribing competencies of future European doctors 
and thereby patient safety.  
Perhaps not surprisingly, most of the included learning outcomes (76%) focused on 
knowledge of basic and clinical pharmacology. This is probably because the initial list of outcomes 
consisted primarily of knowledge outcomes (76%) and because CPT education in Europe is still mainly 
focused on teaching theoretical knowledge (e.g., lectures, written exams) instead of skills (e.g., 
completing drug prescriptions) and attitudes (e.g., communication with patients).10 However, this does 
not necessarily mean that knowledge of basic and clinical pharmacology is more important than skills 
and attitudes related to pharmacotherapy. On the contrary, prescribing skills and attitudes were 
generally considered more important (Figure 2), and these should be taught throughout the medical 
curriculum because they are highly complex cognitive processes that require repeated training.19 
Interestingly, most panellists indicated that skills and attitudes should be acquired during the clinical 
years (years 4–6), and not the preclinical years of medical training, probably because this reflects the 
situation in their own curriculum. Since the training of prescribing skills during the early years of 
medical education has been shown to improve students’ ability to prescribe rationally during later 
years,20,21 prescribing should be taught as early as possible in the curriculum, preferably using 
simulated and clinical environments with real responsibility for patient care.13,22  
In contrast to previous studies,9,13,15,18 in this study the panellists considered knowledge about 
drug marketing, development of drug formularies and guidelines, and complementary and alternative 
medicines less important, on the basis that these topics are not directly relevant for prescribing in daily 
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clinical practice or are usually covered by other courses in the curriculum. Similarly, they considered 
preparing and administering drugs (e.g., intravenous, intramuscular) less important because this role 
has been taken over by nurses and pharmaceutical assistants in many European countries.  
The CPT learning outcomes should be considered in association with a relevant list of core 
drugs (‘student formulary’) and their associated therapeutic problems. These lists may help to prioritize 
learning and avoid overburdening medical students with facts.9 However, only a small proportion of 
European medical schools (4%) use these lists in their CPT programs.10 This might be because it 
takes time and effort to develop a valid list, and this might be a problem for medical schools with a 
limited number of CPT teachers. A potential solution is to develop a European list of core drugs and 
diseases that European medical students should know about by the time they graduate, as previously 
suggested by the EACPT.7 In 2002, Orme et al. published a European list of core drugs and diseases, 
but this probably requires updating.23  
There are two prerequisites for the successful implementation of learning outcomes. First, 
since CPT is often integrated in different courses throughout the medical curriculum, it is important that 
outcomes are compatible with the learning environment and assessment activities (constructive 
alignment).24 Coherence between assessment, teaching strategies and intended learning outcomes is 
important for successful introduction of outcomes and stimulates students to achieve high grades.25 
Currently, CPT learning outcomes in most European medical school are not adequately aligned with 
the curriculum content,10 making this requirement even more important. Second, the purpose of 
introducing learning outcomes is solely to direct teaching and students’ learning, and this should be 
clearly communicated to medical students and teachers. Using outcomes for policy and management 
activities may weaken their function, reducing their potential value.26 
 
Strengths and limitations 
The consensus panel in our study consisted of a large number of experts (n= 129) from various 
professional backgrounds and with different levels of educational experience, and represented most 
European countries. Moreover, the overall response rate was good in comparison with that of other 
studies, highlighting the perceived importance of this topic in Europe. However, there were also 
several limitations. First, due a limited time frame, not all outcomes without 80% agreement could be 
discussed during the 2-hour panel meeting. Therefore, only the most critical outcomes (75–80% 
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agreement) were selected for discussion. Second, since we based our list of learning outcomes only 
on articles published in peer-reviewed journals, we may have missed valuable information from non-
peer reviewed papers such as reports published by educational and pharmacological societies. Third, 
only 26% of the panellists attended the face-to-face meeting. Although this is a relatively small 
proportion, the group represented most participating European countries and was large enough to 
provide a reliable consensus.27 Lastly, there was a poor response from junior doctors. This was most 
likely due to the time involved in participating in the questionnaire rounds. 
 
Conclusion and recommendations 
A large European expert panel reached consensus on 252 learning outcomes that should be included 
in undergraduate CPT curricula to ensure that European medical graduates are able to prescribe 
safely and effectively. Since CPT is a dynamic specialty that is subject to continual change, the 
identified learning outcomes should be reviewed and revised periodically by a European group of CPT 
teachers.  
In order to help medical schools to implement the identified learning outcomes, we provide a 
blueprint of an integrated context-based learning European core curriculum in CPT describing when 
and how the outcomes might be taught and assessed during the early and later years of the medical 
curriculum (Figure 3). This blueprint describes the subcategories of the identified learning outcomes 
(Table 1) together with useful teaching and assessment methods that have been successful at various 
medical schools. Context-based learning refers to learning in the setting that is the same or as similar 
as possible to the setting of the future profession; for medical students that is the clinical practice. CPT 
should be integrated longitudinally as a recurrent theme in modules and attachments throughout the 
medical curriculum, starting as early as possible. We believe that students might acquire a better 
understanding of CPT if it is frequently repeated in different modules over several study years 
compared to one or two distinct courses. In the early years of the medical curriculum (i.e., years 1-3 in 
Europe, and years 1-2 in the USA), the emphasis lies on gaining knowledge of basic and clinical 
pharmacology (e.g., lectures, E-learning), while simultaneously learning to apply this knowledge by 
training prescribing skills in controlled (e.g., case-based discussions) and simulated (e.g., roleplaying 
sessions) environments. In the later years (i.e., years 4-6 in Europe, and years 3-4 in the USA), as 
knowledge increase, more emphasis is given to training prescribing skills in clinical environments (e.g., 
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real-world prescribing, pre-prescribing seminars), while the acquisition of knowledge diminish. During 
the early and later years, most of the teaching time should be devoted to the teaching and training of 
prescribing skills and attitudes since these are highly complex. To ensure that all relevant outcomes 
have been achieved, there should be a robust and separate CPT assessment structure, with no 
compensatory mechanism. Computer-based assessments are useful for testing the knowledge, 
judgement and skills of large cohorts of students since they are relatively quick and easy to mark. 
Moreover, OSCEs are useful to assess the prescribing skills in the early years of the medical 
curriculum, whereas workplace-based assessments are preferred in the later years. The development 
of students’ attitudes can be evaluated using a portfolio. At or near the end of the medical curriculum, 
there should be a valid and reliable summative (national) assessment such as the UK Prescribing 
Safety Assessment28 or Dutch National Pharmacotherapy Assessment29 to assess whether medical 
graduates are able to prescribe safely and effectively. One or more individuals, preferably clinical 
pharmacologists, should be responsible for coordinating all teaching and assessment activities 
throughout the curriculum. Since the proposed blueprint is resource-intensive, clinical pharmacologists 
can and should not work on this alone. Teaching and assessment can be devolved to many other 
teachers throughout the course, often with organ-based specialties. Also, “near-peer” education (e.g., 
junior doctors, medical students) might be helpful to reduce the workload of the usually small group of 
CPT teachers. This blueprint describes how a European core curriculum in CPT might look like but 
can be adapted to suit the local preferences of medical schools, given the differences in institution’s 
culture and resources. 
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Methods  
A Delphi study is a consensus method to determine the extent to which experts agree about a given 
issue. This approach is often used when there is a lack of scientific evidence or when there is 
contradictory evidence on an issue, leading to a diversity of opinions.30,31 It has proven a suitable 
method for determining the content of a CPT curriculum.14,15,17 The modified Delphi process took place 
between January and July 2017 and comprised the following: a systematic literature search; selection 
of a European expert panel; and development of a Web-based questionnaire and its modification in 
two consecutive rounds followed by a face-to-face meeting and final round. This modified Delphi 
process was adopted to minimize time demands on the expert panel. Ethical approval for this study 
was provided by the Dutch Ethics Review Board of Medical Education (Approved Project no. NVMO-
ERB 860).  
 
Systematic literature search 
With the assistance of a medical information specialist, we systematically searched three international 
databases (PubMed, EMBASE, and ERIC) for articles describing CPT learning outcomes  (i.e., 
knowledge, skills and attitudes) in undergraduate medical curricula and published up to 23 January 
2017. Search terms included the following mesh terms as well as a combination of free text words and 
mesh terms in title or abstract: ‘Medical Student’, ‘Medical Graduate’, ‘Medical Undergraduate’, 
‘Medical Education’, ‘Curriculum’, ‘Drug Therapy’, ‘Pharmacotherapy’, ‘Pharmacology’, ‘Prescriptions’, 
‘Prescribing’, ‘Competence’, ‘Expertise’, ‘Knowledge’, ‘Skills’ and ‘Attitudes’. Articles were assessed 
independently for eligibility by two researchers (D.B. and S.d.G.), based on a list of predefined 
inclusion and exclusion criteria. Reference lists from included publications were also screened to 
identify additional papers. Reviews, letters to the editor, editorials, conference abstracts, symposium 
reports, and qualitative studies were excluded. Also, studies were excluded if a specific educational 
intervention or teaching method was evaluated, the language was different from English, German or 
Dutch or if the abstract or full-text was not available. Based on articles identified in the literature search 
(Table S2), specifically the paper by Ross & Maxwell,13 the steering committee extracted a list of 307 
learning outcomes, divided in 35 subcategories. The steering committee consisted of a clinical 
pharmacologist, a junior doctor, an internist-infectious disease specialist, and a senior lecturer in 
prescribing.  
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European expert panel 
We invited European experts in clinical pharmacology, pharmacy, and medical education, as well as 
junior doctors and senior clinicians working in primary and secondary care, to participate in a 
consensus panel. Experts were selected from the EACPT Network of Teachers in Pharmacotherapy 
(NOTIP), a European platform for CPT teachers that supports the development and sharing of 
teaching materials and participation in joint research projects. Participants of previous research 
projects of the EACPT Education Working Group were specifically invited to participate.8,10 All experts 
had to be involved in developing or delivering CPT education to students training in a health 
profession and should have at least 3 years’ educational experience. Participants received an e-mail 
containing information about the general objectives of the study and instructions about the Delphi 
process. Participation was voluntary and informed consent was obtained from all participants.  
 
Data collection and analysis 
We developed a Web-based questionnaire (using surveymonkey.com) containing 307 key learning 
outcomes divided into three categories: knowledge (n= 233), skills (n= 65), and attitudes (n= 9). Minor 
modifications to the content were made after a pilot study with seven European CPT teachers.  
In the first round, panellists were asked to rate each outcome (1= very unimportant, 2= 
unimportant, 3= neutral, 4= important, 5= very important), indicating their agreement that the outcome 
should be included in the undergraduate CPT curriculum and should be expected of European 
graduates in order that they can prescribe safely and effectively. If panellists awarded an outcome a 
score of 4 or 5, they were asked to indicate whether that outcome should be acquired during the 
preclinical (i.e. bachelor’s degree) or clinical (i.e. master’s degree, clerkships) years of the curriculum, 
or both. Additionally, panellists could also change the wording of outcomes and add new outcomes if 
they felt these were missing. An outcome was included if ≥80% of the experts gave it a score of 4 or 5. 
This cut-off is in line with a similar study14 and was chosen in order to create a list of ‘need to know’ 
learning outcomes rather than one with ‘nice to know’ outcomes. 
In the second round, panellists were shown which outcomes did not meet the 80% agreement 
cut-off in the first round, the additional suggested outcomes, and the group score for each outcome. 
Panellists were asked to reconsider each outcome based on the group opinion using the same 5-point 
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scale. They had the opportunity to justify their point of view in an open text box. During these two 
rounds, panellists were anonymous to other panellists and individual scores were confidential. 
Panellists were invited to attend a 2-hour face-to-face meeting during the 13th congress of the 
European Association of Clinical Pharmacology and Therapeutics (EACPT; www.eacpt2017.org). 
During this meeting, panellists discussed the outcomes with 75–80% agreement after Round 2 and 
were asked to vote (yes, no, unsure) for acceptance, rejection, or modification. Voting was anonymous 
via mobile devices. In the third round, panellists were asked to rate outcomes that had been rephrased 
during the panel meeting using the 5-point scale. A summary of the arguments for and against 
changes was provided. Panellists were allowed 3 weeks to complete each questionnaire round; 
reminders were sent after 1 and 2 weeks. After each round, responses were downloaded in Excel 
format and analyzed descriptively using IBM SPSS version 22.0 (Chicago, IL).  
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Study highlights 
 
What is the current knowledge on the topic? 
A recent study showed that the prescribing competencies of final-year medical students in Europe 
were poor, resulting in many potentially harmful prescribing errors. Another recent study showed 
marked variation in the quantity and quality of CPT education within and between European countries. 
Harmonizing CPT education at a European level might improve the prescribing competencies of future 
doctors, but to date there is no consensus on the required learning outcomes for European graduates 
in order to prescribe safely and effectively.  
 
What question did this study address? 
In this modified Delphi study, key learning outcomes were identified for teaching and assessing CPT in 
undergraduate medical curricula in Europe. 
 
What does this study add to our knowledge? 
A large European expert panel reached consensus on 252 key learning outcomes that should be 
included in undergraduate CPT curricula to ensure that European graduates are able to prescribe 
safely and effectively. Additionally, we provide a blueprint of a European core curriculum in CPT 
describing when and how the learning outcomes might be taught and assessed during the 
undergraduate medical curriculum. 
 
How might this change clinical pharmacology or translational science? 
A European core curriculum in CPT might help to harmonize CPT education and improve the 
prescribing competencies of future European doctors and thereby patient safety.  
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Titles and legends 
 
Table 1 Subcategories of learning outcomes that were included (n= 34). 
 
Figure 1 Flowchart of the systematic literature search. 
 
Figure 2 Total number of learning outcomes per subcategory (n= 34) for knowledge (    ; n= 192), 
skills (    ; n= 47) and attitudes (    ; n= 13). The red line demonstrates the mean % ‘(very) important’ 
per subcategory (calculated by dividing the total % ‘(very) important’ per subcategory by the number of 
outcomes within that subcategory). TDM, Therapeutic Drug Monitoring.   
 
Figure 3 Blueprint of an integrated context-based European core curriculum in clinical pharmacology 
and therapeutics describing when and how learning outcomes might be taught and assessed during 
the early (i.e., years 1-3 in Europe and years 1-2 in the USA) and later years (i.e., years 4-6 in Europe 
and years 3-4 in the USA) of the medical curriculum. Journal clubs refer to discussing the scientific 
CPT literature in small groups of students in order to teach critical appraisal skills. Case-based 
discussion groups involve discussing written patient cases in small groups of students together with a 
tutor. Role-playing sessions refers to conducting therapeutic consultations with simulated patients. 
Pre-prescribing seminars involve medical students writing instructions on in-patient drug charts, which 
have to be validated by a doctor before drugs are dispensed. Prescribing tutorials involve ward-based 
practical tutorials about common therapeutic problems and high risk medicines for medical students 
during clinical attachments. Student-run clinics are real patient clinics designed to teach and train 
prescribing skills grounded in a real-life context and to provide students with early clinical experience 
and responsibility under the supervision of a senior clinician. Roleplaying sessions involve therapeutic 
consultations with standardised patients in a simulated setting. Workplace-based assessment entails 
direct observation of prescribing in clinical practice under the supervision of a senior clinician. OSCE, 
objective structured clinical examination.  
 
Table S1 Characteristics of the European consensus panel (n= 129).  
 
Table S2 Articles (n= 23) identified in the systematic literature search. 
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Table S3 Learning outcomes for knowledge in clinical pharmacology and therapeutics (n= 192) that 
were included (≥80% of the panellists scored ‘important’ or ‘very important’). 
 
Table S4 Learning outcomes for skills in clinical pharmacology and therapeutics (n= 47) that were 
included (≥80% of the panellists scored ‘important’ or ‘very important’). 
 
Table S5 Learning outcomes for attitudes to clinical pharmacology and therapeutics (n= 13) that were 
included (≥80% of the panellists scored ‘important’ or ‘very important’). 
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Table 1 Subcategories of learning outcomes that were included (n= 34).  
 
Competence Subcategory (n= 34) Number of learning 
outcomes (n= 252) 
Knowledge  1. Introduction to clinical pharmacology and therapeutics   
1.1 Basic Principles 
1.2 Drugs in health care and society  
5 
2. Pharmacodynamics  
2.1 Mechanism of action 
2.2 Dose-response relationships 
12 
3. Pharmacokinetics  
3.1 Drug absorption, distribution, metabolism and excretion 
3.2 Concentration-time relationships 
3.3 Repeated drug dosing 
21 
4. Individual variability in the response to drugs  
4.1. Basic principles 
4.2. Pharmacokinetic variability 
4.3. Pharmacogenetic variability 
11 
5. Adherence, compliance and concordance 
5.1 Adherence and compliance 
5.2 Concordance 
8 
6. Therapeutic Drug Monitoring 
6.1 Basic principles 
6.2 Using drug effect and concentration 
10 
7. Adverse drug reactions  
7.1. Basic principles 
7.2. Drug allergy 
7.3. Diagnosis, management and prevention 
7.4. Pharmacovigilance 
17 
8. Drug interactions and contraindications  
8.1 Interactions 
8.2 Contraindications 
11 
9. Medication errors 4 
10. Drug discovery, development and regulation   
10.1  Drug discovery and development 
10.2  Drug regulation 
7 
11. Medicines management  
10.1  National and local processes 
10.2  Formularies and guidelines 
7 
12. Evidence based prescribing 
12.1  Basic principles 
12.2  Critical appraisal of clinical studies 
12.3  Find reliable information about drugs 
12 
13. Legal and ethical aspects of prescribing  10 
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13.1  Legal aspects 
13.2  Ethical aspects 
14. Prescribing for patient with special requirements  
14.1  Elderly patients 
14.2  Impaired liver function 
14.3  Impaired renal function 
14.4  Pregnant women and women of childbearing potential 
14.5  Lactation 
14.6  Children 
29 
15. Rational prescribing  
15.1  Rational approach to prescribing 
15.2  Dose selection 
6 
16. Clinical toxicology 6 
17. Misuse of drugs 2 
18. Complementary and alternative medicine 2 
19. Use of antibiotics and antibiotic resistance 4 
20. Commonly used drugs and high risk medicines 8 
Skills 21. Medication history taking 7 
22. Rational prescribing 11 
23. Drug dose calculation 3 
24. Prescription writing 4 
25. Non-drug therapy 1 
26. Communication 5 
27. Reviewing prescriptions 3 
28. Adverse drug reactions 4 
29. Clinical toxicology 2 
30. Obtaining information from guidelines and protocols to support prescribing 3 
31. Monitoring medication 4 
Attitudes 32. Risk-benefit analysis 7 
33. Recognizing personal limitations in knowledge 1 
34. Recognition of a balanced approach to the introduction of new drugs 5 
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2883 Articles identified through 
database searching 
2017 Articles remaining and 
screened after duplicates removed
134 Full-text articles assessed for 
eligibility
18 Articles selected for further 
analysis
1883 Articles excluded 
based on title/abstract
116 Full-text articles excluded:
- 55 no learning outcomes
- 24 no orginal articles
- 3 no CPT education
- 8 no full article available
- 4 no medical students
- 2 no English language 
- 20 other
23 Articles included
307 Learning outcomes extracted 
by the steering committee
5 References added
.
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